Scuderi et al. reported that treatment with VIP significantly restored both claudin-1 and ZO-1 expression, and increased barrier integrity, in hyperglycemia-induced ARPE-19 cells [34]. This evidence concerns the gene CLDN1 and Hyperglycemia.